Related Experiment Video
Updated: Nov 16, 2025

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
Published on: February 5, 2020
Immune-related cutaneous adverse events due to checkpoint inhibitors
Evelyn Wang1, Lukas Kraehenbuehl2, Kwami Ketosugbo3
1Department of Pediatrics, National Jewish Health, Denver, Colorado.
Objective:
To familiarize the reader with the most common cutaneous adverse events with immune checkpoint inhibitors (CPIs) and their grading and treatment.
Data Sources:
Recent research articles, relevant review articles, and case series/reports in English from the PubMed database mostly, from 2010 onward.
Study Selections:
Most data are from retrospective studies and case series. Older studies regarding the mechanism were included if they were of particular importance.
Results:
An understanding of this review should enable the reader to identify specific skin disorders in patients receiving immune CPIs, grade the adverse event, and be able to treat or refer the patient as needed.
Conclusion:
Allergists/immunologists need to be familiar with these immune-related cutaneous adverse events because their incidence will increase with the ever-expanding use of CPIs and, in particular, because patients will certainly continue to be referred suspecting drug allergies.
Related Concept Videos
Tumor Immunotherapy
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Cell-mediated Immune Responses
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

